ROSIGLITAZONE BASE

Rosiglitazone base is a PPAR agonist that enhances insulin sensitivity in type 2 diabetes. Side effects include weight gain, edema, heartfailure risk, bone fractures, and hepatotoxicity. Only GMP materials will be supplied, logistics all according to GDP.

SKU: 0f6fb4d8d4f3 Category: Tag:

Product Description


Mechanism of Action

ROSIGLITAZONE BASE displays a multidimensional biochemical activity profile integrating modulation of enzymatic pathways, receptormediated signalling, mitochondrial bioenergetics, oxidativestress homeostasis, ionchannel dynamics, membrane structural behaviour and transcriptionfactor regulation. Structural modelling suggests interactions with catalytic residues, allosteric microdomains, transmembrane helices, signalling cofactors and cytoskeletal complexes. These interactions enable influence over phosphorylation cascades, secondmessenger flux (Ca²⁺, IP, DAG, cAMP), ROS balance, ATP turnover, membranepotential stability and organelle stressresponse thresholds.

Benefits and Applications

  • Receptorligand affinity analysis and docking studies
  • Enzymekinetic profiling and catalyticflux pathway mapping
  • Mitochondrialfunction modelling and ATP/ROS system evaluation
  • Transcriptomic, metabolomic, proteomic and phosphoproteomic profiling
  • Cytoskeletalarchitecture and membranedynamics exploration
  • Apoptosis, autophagy, necroptosis and ferroptosis pathway modelling
  • SAR/QSAR modelling and compoundoptimisation workflows
  • Mechanistic pharmacodynamics and doseresponse simulation

Side Effects and Risks

  • Oxidativestress imbalance and elevated ROS
  • Mitochondrial overload or respiratorychain suppression
  • Disruption of Ca²⁺/Na⁺/K⁺ ionhomeostasis
  • Unintended receptor crosstalk or inhibitory signal interference
  • Cytoskeletal destabilisation and membrane-integrity reduction
  • Dosedependent cytotoxicity or programmed-cell-death activation
  • Transcriptional and epigenetic instability
  • Inflammatorycascade activation (NF-κB, MAPK, JNK)

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C18H19N3O3S

Molecular Weight

357.4 g/mol

CAS Number

122320-73-4

Storage Condition

Keep container tightly closed in a dry and well-ventilated place. Recommended storage temperature 2 – 8 °C.

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

rosiglitazone; 122320-73-4; Rosiglizole; Brl-49653; Rezult

IUPAC/Chemical Name

5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione

InChl Key

YASAKCUCGLMORW-UHFFFAOYSA-N

InChl Code

InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23)

References

https://pubchem.ncbi.nlm.nih.gov/compound/77999;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download